These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9657478)

  • 1. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects.
    Kirchhof PF; Fabritz CL; Franz MR
    Circulation; 1998 Jun; 97(25):2567-74. PubMed ID: 9657478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiodarone-induced postrepolarization refractoriness suppresses induction of ventricular fibrillation.
    Kirchhof P; Degen H; Franz MR; Eckardt L; Fabritz L; Milberg P; Läer S; Neumann J; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2003 Apr; 305(1):257-63. PubMed ID: 12649377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
    Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness.
    Wang J; Bourne GW; Wang Z; Villemaire C; Talajic M; Nattel S
    Circulation; 1993 Sep; 88(3):1030-44. PubMed ID: 8353865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine.
    Stark U; Stark G; Kasper K; Schwarzl I; Decrinis M; Pilger E; Tritthart HA
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procainamide-induced changes in reentrant ventricular tachycardia with special reference to the tachycardia-interrupting critical paced cycle length during transient entrainment with rapid pacing.
    Aizawa Y; Naitoh N; Washizuka T; Kitazawa H; Takahashi K; Kodama I; Shibata A
    Jpn Heart J; 1994 Sep; 35(5):611-23. PubMed ID: 7830326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic drug effects on premature beats are partly determined by prior cardiac activation frequency in perfused guinea-pig heart.
    Osadchii OE
    Exp Physiol; 2020 May; 105(5):819-830. PubMed ID: 32175633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New classification of moricizine and propafenone based on electrophysiologic and electrocardiographic data from isolated rabbit heart.
    Koller B; Franz MR
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):753-60. PubMed ID: 7532753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced post-repolarization refractoriness as an antiarrhythmic principle and its underlying mechanism.
    Franz MR; Gray RA; Karasik P; Moore HJ; Singh SN
    Europace; 2014 Nov; 16 Suppl 4():iv39-iv45. PubMed ID: 25362169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
    Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
    Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of procainamide on the postrepolarization refractoriness in cardiac muscle: evaluation using the block coupling interval in the artificial isthmus model in the canine right atrium.
    Yoshizawa N; Niwano S; Moriguchi M; Kitano Y; Inuo K; Saito J; Izumi T
    Pacing Clin Electrophysiol; 2001 Jul; 24(7):1100-7. PubMed ID: 11475826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of procainamide and propafenone on the composition of the excitable gap in canine atrial reentry tachycardia.
    Derakhchan K; Pagé P; Lambert C; Kus T
    J Pharmacol Exp Ther; 1994 Jul; 270(1):47-54. PubMed ID: 8035342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency-dependent effects of propafenone decrease with duration of ventricular tachycardia in isolated guinea pig hearts.
    Stark G; Dhein S; Bachernegg M; Ziskoven U; Zhao Y; Klaus W; Kickenweiz E; Decrinis M; Tritthart HA
    Eur J Pharmacol; 1994 Feb; 252(3):283-9. PubMed ID: 8162951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of procainamide's effect on conduction by cellular uncoupling in perfused rabbit hearts.
    Spear JF; Hook BG; Josephson ME; Moore EN
    J Cardiovasc Electrophysiol; 1997 Feb; 8(2):199-214. PubMed ID: 9048250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propafenone slows conduction and produces a nonuniform recovery of excitability between Purkinje and ventricular muscle fibers.
    Tamargo J
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):203-7. PubMed ID: 7692158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into the beneficial electrophysiologic profile of ranolazine in heart failure: prevention of ventricular fibrillation with increased postrepolarization refractoriness and without drug-induced proarrhythmia.
    Frommeyer G; Rajamani S; Grundmann F; Stypmann J; Osada N; Breithardt G; Belardinelli L; Eckardt L; Milberg P
    J Card Fail; 2012 Dec; 18(12):939-49. PubMed ID: 23207083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of procainamide-induced prevention of spontaneous wave break during ventricular fibrillation. Insight into the maintenance of fibrillation wave fronts.
    Kim YH; Yashima M; Wu TJ; Doshi R; Chen PS; Karagueuzian HS
    Circulation; 1999 Aug; 100(6):666-74. PubMed ID: 10441106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.